As of 1st June 2009 Premarin® (conjugated oestrogens) and Premia Continuous® (conjugated oestrogens plus medroxyprogesterone acetate) will no longer be available for subsidised supply through the Pharmaceutical Benefits Schedule (PBS) in Australia; however, both will continue to be available as a private prescription.
According to the manufacturer, the reason for this is due to increased costs associated with the manufacture of these two preparations.
The table below outlines oral oestrogen preparations (oestrogen as a sole ingredient) that are currently available in Australia and their approximate daily doses. Should patients be unable to obtain Premarin® or Premia Continuous® via a private prescription, the PBS eligibility of the various preparations is also listed.
Read the complete article: Premarin® and Premia Continuous® Alternatives (433) Volume 34 (1): May 4, 2009
The 2009 RGH E-Bulletins are archived here.
A joint initiative of the Patient Services Section and the Drug and Therapeutics Information Service of the Pharmacy Department, Repatriation General Hospital, Daw Park, South Australia. The RGH Pharmacy E-Bulletin is distributed in electronic format on a weekly basis, and aims to present concise, factual information on issues of current interest in therapeutics, drug safety and cost-effective use of medications.
Editor: Assoc. Prof. Chris Alderman, University of South Australia – Director of Pharmacy, RGH © Pharmacy Department, Repatriation General Hospital, Daw Park, South Australia 5041.
If you like this post and what else you see on the blog please subscribe by RSS feed (the orange button) or by email. Visit my subscription page.
{ 1 comment }
